Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test may predict lung cancer return after surgery

NCT ID NCT07242482

Not yet recruiting Knowledge-focused Sponsor: Zhao Jun Source: ClinicalTrials.gov ↗

First seen Nov 21, 2025 · Last updated May 21, 2026 · Updated 28 times

Summary

This study aims to see if certain immune markers in the blood can help predict how lung cancer patients will do after surgery. Researchers will measure specific immune cells in 200 non-small cell lung cancer patients before and after their operation. The goal is to find patterns that could forecast whether the cancer comes back or how long patients survive.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Soochow university, Suzhou, Jiangsu 215000

    Suzhou, Jiangsu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.